Anzeige
Mehr »
Login
Mittwoch, 16.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
7 neue Bohrlöcher bei Best Chance: Gladiator Metals (WKN: A3D6HK) bereit für ein Ressourcen-Update
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
27.09.Vicebio raises $100m for vaccines and other bio financings
26.09.Mirai Bio launches with plan to help genetic med developers
26.09.AZ gets sought-after lung cancer approval for Tagrisso
26.09.Second Niemann-Pick approval brings more hope to patients
26.09.Obesity drug developer BioAge raises $198m in IPO
26.09.Pfizer pulls sickle cell med Oxbryta off market after deaths
26.09.MSD hits a hurdle with its LAG-3 programme
25.09.Aurion launches eye disease cell therapy in its first market
25.09.Novo Nordisk CEO reticent on lowering semaglutide prices
25.09.Surfing on new Duchenne data, Wave charges $175m offering
25.09.Lilly gets second approval, in Japan, for Alzheimer's drug
25.09.AI firm Generate signs $1bn discovery deal with Novartis
24.09.MHRA's AI as medical device pilot opens for applicants
24.09.Astellas claims EU okay for first claudin 18.2 cancer drug
24.09.UCB, Biogen lupus drug scores in phase 3 trial
24.09.Roche launches 'revolutionary' pathogen detection tech
24.09.Ipsen crosses EU finish line with Alagille syndrome drug
23.09.FDA clears RHYTHM AI's new algorithm for atrial fibrillation
23.09.Sanofi's Sarclisa gets one up on rival Darzalex in myeloma
23.09.FDA clears first drug for Niemann-Pick disease
23.09.J&J tries to push talc bankruptcy over the line once again
23.09.FTC sues PBMs over 'perverse' rebate system
20.09.Sanofi's tolebrutinib cuts MS progression by 31% in trial
20.09.J&J nets another key approval for blockbuster hope Rybrevant
20.09.Job losses loom at Achilles as TIL therapy platform is cut